Effect of curcumin on hepatic antioxidant enzymes activities and gene expressions in rats intoxicated with aflatoxin B1

Phytotherapy Research

Volumn 29, Issue 1, 2015, Pages 134-140

  El Bahr, S M ^a,b  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b Alexandria University   (Egypt)

Author keywords

Antioxidants; Biomarkers; Curcuma longa; Liver damage; Oxidative stress

Indexed keywords

AFLATOXIN B1; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA ACTIN; CATALASE; CURCUMIN; GLOBULIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MESSENGER RNA; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ANTIOXIDANT; LIPID PEROXIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; LIPID PEROXIDATION; LIVER INJURY; LIVER PROTECTION; LIVER STRUCTURE; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; UPREGULATION; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION; LIVER; METABOLISM; OXIDATION REDUCTION REACTION;

CURCUMA LONGA; RATTUS;

AFLATOXIN B1; ANIMALS; ANTIOXIDANTS; CATALASE; CURCUMIN; GENE EXPRESSION; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; LIPID PEROXIDATION; LIPID PEROXIDES; LIVER; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84921031821     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5239     Document Type: Article

References (44)

1. Ahmad H, Jinke T, Wang J, et al. 2012. Effect of dietary sodium selenite and selenium yeast on antioxidant enzymes and oxidative stability of chicken breast meat. J Agri Food Chem 60: 7111-7220.
2. Ahmed T, Gilani AH. 2014. Therapeutic potential of turmeric in Alzheimer's disease: curcumin or curcuminoids? Phytother Res 28: 517-525.
3. Bancroft JD, Gamble M. 2002. Theory and Practice of Histological Techniques (5th edn). Churchill Livingstone: London, New York and Philadelphia.
4. Belcaro G, Hosoi M, Pellegrini L, et al. 2014. A controlled study of a lecithinized delivery system of curcumin (Meriva®) to alleviate the adverse effects of cancer treatment. Phytother Res 28: 444-450.
5. Busby W, Wogan G. 1984. Aflatoxins. Chemical carcinogens. Am Chem Soc Monogr 2: 954-1136.
6. Chainani-Wu N. 2003. Safety and anti-inflammatory activity of curcumin: a component of turmeric (curcumin longa). J Altern Comp Med 9: 161-168.
7. Cheng Y, Li HL, Wang HF, et al. 2003. Inhibition of nicotine-DNA adducts formation in mice by six dietary constituents. Food Chem Toxicol 41: 1045-1050.
8. Cullen JM, Newberne PM. 1994. Acute hepatotoxicity of aflatoxins. In Toxicol. Aflatoxins. Eaton DL, Groopman JD (eds). Academic Press: San Diego, California; 3-26.
9. El-Agamy D. 2010. Comparative effects of curcumin and resveratrol on aflatoxin B1 induced liver injury in rats. Arch Toxicol 84: 389-396.
10. El-Bahr SM. 2007. Effect of black cumin seeds (Nigella sativa) on the profile of serum lipids, lipoproteins and fatty acids in pekin ducklings. Int J Appl Chem (IJAC) 3: 221-230.
11. El-Bahr SM. 2013. Curcumin regulates gene expression of insulin like growth factor, B-cell CLL/lymphoma 2 and antioxidant enzymes in streptozotocin induced diabetic rats. BMC Complem Altern M 13: 368-379.
12. Farombi EO, Adepoju BF, Ola-Davies OE, Emerole GO. 2005. Chemoprevention of aflatoxin B1-induced genotoxicity andhepatic oxidative damage in rats by kolaviron, a natural biflavonoid of Garcinia kola seeds. Eur J Cancer Prev 14: 207-214.
13. García-Niño WR, Pedraza-Chaverrí J. 2014. Protective effect of curcumin against heavy metals-induced liver damage. Food Chem Toxicol 69: 182-201.
14. Goto T, Wicklow DT, Ito Y. 1996. Aflatoxin and cyclopiazonic acid production by a sclerotium-producing Aspergillus tamarii strain. Appl Environ Microbiol 62: 4036-4038.
15. Gupta SC, Patchva S, Koh W, Aggarwal BB. 2012. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 39: 283-299.
16. Jiménez-Flores LM, López-Briones S, Macías-Cervantes MH, Ramírez-Emiliano J, Pérez-Vázquez V. 2014. A PPARγ, NF-κ B and AMPK-dependent mechanism may be involved in the beneficial effects of the curcumin in diabetic db/db Mice Liver. Molecules 19: 8289-8302.
17. Kamdem L, Magdalou J, Siest G, Ban M, Zissu D. 1983. Induced hepatotoxicity in female rats by aflatoxin B1 and ethynylestradiol interaction. Toxicol Appl Pharmacol 67: 26-40.
18. Marczuk-Krynicka D, Hryniewiecki T, Piatek J, Paluszak J. 2003. The effect of brief food withdrawal on the elevation of free radicals and other parameters of oxidative status in the liver. Med Sci Monit 9: 131-135.
19. Mathuria N, Verma RJ. 2007. Curcumin ameliorates aflatoxin-induced lipid peroxidation in liver, kidney and testis of mice: an in vitro study. Acta Pol Pharm 64: 413-416.
20. Mathuria N, Verma RJ. 2008. Curcumin ameliorates aflatoxin-induced lipid-peroxidation in liver and kidney of mice. Acta Pol Pharm 65: 195-202.
21. McKillop IH, Moran DM, Jin X, Koniaris LG. 2006. Molecular pathogenesis of hepatocellular carcinoma. J Surg Res 136: 125-135.
22. Meki AR, Abdel-Ghaffar SK, El-Gibaly I. 2001. Aflatoxin B1 induces apoptosis in rat liver: protective effect of melatonin. Neuroendocrinol Lett 22: 417-426.
23. Neerati P, Devde R, Gangi AK. 2014. Evaluation of the Effect of Curcumin Capsules on Glyburide Therapy in Patients with Type-2 Diabetes Mellitus. Phytother Res. DOI: 10.1002/ptr.5201.
24. Panahi Y, Badeli R, Karami N, Sahebkar A. 2014a. Investigation of the Efficacy of Adjunctive Therapy with Bioavailability-Boosted Curcuminoids in Major Depressive Disorder. Phytother Res. DOI: 10.1002/ptr.5211.
25. Panahi Y, Rahimnia AR, Sharafi M, Alishiri G, Saburi A, Sahebkar A. 2014b. Curcuminoid Treatment for Knee Osteoarthritis: A Randomized Double-Blind Placebo Controlled Trial. Phytother Res. DOI: 10.1002/ptr.5174.
26. Panahi Y, Saadat A, Beiraghdar F, Sahebkar A. 2014c. Adjuvant Therapy with Bioavailability-Boosted Curcuminoids Suppresses Systemic Inflammation and Improves Quality of Life in Patients with Solid Tumors: A Randomized Double-Blind Placebo-Controlled Trial. Phytother Res. DOI: 10.1002/ptr.5149.
27. Quezada T, Cuellar H, Jaramillo-Juarez F, Valdivia AG, Reyes JL. 2000. Effects of aflatoxin B1 on the liver and kidney of broiler chickens during development. Comp Biochem Physiol C, Toxicol Pharmacol 125: 265-272.
28. Recknagel RO, Glende EA, Dolak JA, Waller RL. 1989. Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther 43: 139-154.
29. Roebuck BD, Maxuitenko YY. 1994. The toxicology of Aflatoxins: Human health, veterinary and agricultural significance, Academic Press, San Diego.
30. Sahebkar A, Mohammadi A, Atabati A, et al. 2013. Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytother Res 27: 1883-1888.
31. Sanmukhani J, Satodia V, Trivedi J, et al. 2014. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res. DOI: 10.1002/ptr.5025
32. SAS 2002. Statistical Analysis System (1st edn). SAS Institute Inc., Cary, NC, USA.
33. Sharma V, Sharma C, Paliwal R, Pracheta Sharma S. 2011. Ameliorative effects of curcuma Longa and curcumin on aflatoxin B1 induced serological and biochemical Changes in kidney of male mice. Asian J Biochem Pharmaceut Res 2: 338-351.
34. Smela ME, Currier SS, Bailey EA, Essigmann JM. 2001. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. Carcinogenesis 22: 535-545.
35. Stresser DM, Bailey GS, Williams DE. 1994. Indole- 3-carbinol and β-naphthoflavone induction of aflatoxin B1 metabolism and cytochrome P450 associated with bioactivation and detoxication of aflatoxin B1 in the rat. Drug Metab Dispos 22: 383-391.
36. Thongrakard V, Titone R, Follo C, et al. 2014. Turmeric Toxicity in A431 Epidermoid Cancer Cells Associates with Autophagy Degradation of Anti-apoptotic and Anti-autophagic p53 Mutant. Phytother Res. DOI: 10.1002/ptr.5196.
37. Towner RA, Qian SY, Kadiiska MB, Mason RP. 2003. In vivo identification of aflatoxin-induced free radicals in rat bile. Free Radic Biol Med 35: 1330-1340
38. Trujillo J, Chirino YI, Molina-Jijón E, Andérica-Romero AC, Tapia E, Pedraza-Chaverrí J. 2013. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol 1: 448-456
39. Umarani M, Shanthi P, Sachdanandam P. 2008. Protective effect of Kalpaamruthaa in combating the oxidative stress posed by aflatoxin B(1)-induced hepatocellular carcinoma with special reference to flavonoid structure-activity relationship. Liver Int 28: 200-213.
40. Wei QY, Chen WF, Zhou B, Yang L, Liu ZL. 2006. Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues. Biochim Biophys Acta 1760: 70-77.
41. Yamauchi Y, Izumi Y, Yamamoto J, Nomori H. 2014. Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells. Phytother Res 28: 728-735.
42. Yarru LP, Settivari RS, Gowda NKS, Antoniou E, Ledoux DR, Rottinghaus GE. 2009. Effects of turmeric (Curcuma longa) on the expression of hepatic genes associated with biotransformation, antioxidant, and immune systems in broiler chicks fed aflatoxin. Poult Sci 88: 2620-2627.
43. Yousef MI, Salem MH, Kamel KI, Hassan GA, El-Nouty FD. 2003. Influence of ascorbic acid supplementation on the haematological and clinical biochemistry parameters of male rabbits exposed to aflatoxin B1. J Environ Sci Health B 38: 193-209.
44. Zheng S, Yumei F, Chen A. 2007. De novo synthesis of glutathione is a prerequisite for curcumin to inhibit HSC activation. Free Radic Biol Med 43: 444-453.